Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F.
Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003.
Points & Pearls: Cannabinoids: emerging evidence in use and abuse.
Williams MV, Gupta N, Nusbaum J.
Emerg Med Pract. 2018 Aug 1;20(Suppl 8):1-2.
Synthetic cannabinoids as drugs of abuse.
Ashton JC.
Curr Drug Abuse Rev. 2012 Jun;5(2):158-68. doi: 10.2174/1874473711205020158.
Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations.
Echeverria-Villalobos M, Todeschini AB, Stoicea N, Fiorda-Diaz J, Weaver T, Bergese SD.
J Clin Anesth. 2019 Nov;57:41-49. doi: 10.1016/j.jclinane.2019.03.011. Epub 2019 Mar 7.
Cannabinoids: emerging evidence in use and abuse.
Williams MV.
Emerg Med Pract. 2018 Aug;20(8):1-20. Epub 2018 Aug 1.
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L.
Toxins (Basel). 2021 Feb 5;13(2):117. doi: 10.3390/toxins13020117.
Drug addiction.
Camí J, Farré M.
N Engl J Med. 2003 Sep 4;349(10):975-86. doi: 10.1056/NEJMra023160.
A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.
Bae K, Kwon NJ, Han E.
Forensic Sci Int. 2018 Nov;292:45-49. doi: 10.1016/j.forsciint.2018.09.008. Epub 2018 Sep 19.
Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
Arellano AL, Papaseit E, Romaguera A, Torrens M, Farré M.
CNS Neurol Disord Drug Targets. 2017;16(5):554-566. doi: 10.2174/1871527316666170413104516.
Synthetic Cannabinoids.
Mills B, Yepes A, Nugent K.
Am J Med Sci. 2015 Jul;350(1):59-62. doi: 10.1097/MAJ.0000000000000466.
